Avadel Pharmaceuticals plc has published six manuscripts in a CNS Drugs supplement titled "A New Dawn in the Management of Narcolepsy," focusing on clinical management strategies, shared ...

What Is Wakix, and Why Does It Matter? Wakix (pitolisant) is a prescription medication used to treat narcolepsy, a long-term neurological sleep disorder that causes excessive daytime sleepiness and, ...

The Food and Drug Administration approved the first generic version of Jazz Pharmaceutical’s drug Xyrem to treat patients with narcolepsy. The generic drug, developed by Roxane Laboratories, is ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Alkermes’ investigational ...

One of biotech’s longest-tenured leaders, Pops steered Alkermes through several reinventions, the latest of which has made it ...

Takeda Pharmaceutical Co.’s experimental narcolepsy drug significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the root cause of the ...

The "United States Narcolepsy Drugs Market to Reach US$ 2,233.56 Million by 2033 - 7.88% CAGR Driven by Novel Therapies and Better Diagnosis" report has been added to ResearchAndMarkets.com's offering ...

Avadel Pharmaceuticals (NASDAQ:AVDL) slipped by 25.63% in after-hours on Wednesday after it missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by ...

CHICAGO -- Novel orexin receptor 2 agonist oveporexton normalized wakefulness for most people with narcolepsy type 1 in two randomized phase III trials. Mean sleep latency across four, 40-minute ...

PLYMOUTH MEETING, Pa., February 17, 2026--(BUSINESS WIRE)--Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Positive late-stage trial ...